As of 2025-07-19, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (32.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -982.2%.
The range of the Relative Valuation is (31.56) - (31.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 18.0x | 17.7x |
| Forward P/E multiples | 17.9x - 20.0x | 18.8x |
| Fair Price | (31.56) - (31.80) | (32.20) |
| Upside | -964.5% - -971.3% | -982.2% |
| Date | P/E |